PROVIDER AND PARTNER INTERACTIONS IN THE TREATMENT DECISION-MAKING PROCESS FOR NEWLY DIAGNOSED LOCALIZED PROSTATE CANCER

2011 ◽  
Vol 108 (6) ◽  
pp. 856-857
Author(s):  
Robert Pickard
2011 ◽  
pp. no-no ◽  
Author(s):  
Steven B. Zeliadt ◽  
David F. Penson ◽  
Carol M. Moinpour ◽  
David K. Blough ◽  
Catherine R. Fedorenko ◽  
...  

2021 ◽  
Vol 15 (4) ◽  
pp. 155798832110268
Author(s):  
Timothy A Skyring ◽  
Kylie J Mansfield ◽  
Judy R Mullan

For men with newly diagnosed prostate cancer the decisions about treatment options are complex and difficult. The aim of this study was to investigate any association between the extent to which men wanted to be involved in the decision making process, their satisfaction with that process, and their levels of decision regret after treatment. The study population consisted of men diagnosed with prostate cancer at a regional center in Australia. Men ( n = 324) were invited to complete a mail out survey which included demographic questions, the treatment chosen, and three validated tools: The Control Preference Scale to measure the degree of control assumed when making decisions about medical interventions; the Treatment Decision-Making Satisfaction Scale (TDM- SAT) to assess satisfaction with the treatment decision making process; and the Decision Regret Scale to assess the level of regret after treatment. The majority of the 151 respondents (47% response rate) expressed an active decision control preference. There was no correlation between age and the treatment chosen or the degree of control men exerted over the decision-making process. Men who preferred a passive role were less satisfied with the decision-making process than were those who took an active or collaborative approach. A strong inverse correlation was demonstrated between regret experienced and satisfaction with the decision-making process. In conclusion, for men newly diagnosed with prostate cancer, taking an active role in the treatment decision making process led to greater satisfaction with that process, which in turn reduced their chances of experiencing regret following treatment.


2018 ◽  
Vol 13 (7) ◽  
Author(s):  
Mustafa Andkhoie ◽  
Desneige Meyer ◽  
Michael Szafron

Introduction: The purpose of this research is to gather, collate, and identify key factors commonly studied in localized prostate cancer (LPC) treatment decision-making in Canada and the U.S.Methods: This scoping review uses five databases (Medline, EMBASE, CINAHL, AMED, and PsycInfo) to identify relevant articles using a list of inclusion and exclusion criteria applied by two reviewers. A list of topics describing the themes of the articles was extracted and key factors were identified using principal component analysis (PCA). A word cloud of titles and abstracts of the relevant articles was created to identify complementary results to the PCA.Results: This review identified 77 relevant articles describing 32 topics related to LPC treatment decision-making. The PCA grouped these 32 topics into five key factors commonly studied in LPC treatment decision-making: 1) treatment type; 2) socioeconomic/demographic characteristics; 3) personal reasons for treatment choice; 4) psychology of treatment decision experience; and 5) level of involvement in the decision-making process. The word cloud identified common phrases that were complementary to the factors identified through the PCA.Conclusions: This research identifies several possible factors impacting LPC treatment decision-making. Further research needs to be completed to determine the impact that these factors have in the LPC treatment decision-making experience.


PLoS ONE ◽  
2015 ◽  
Vol 10 (11) ◽  
pp. e0142812 ◽  
Author(s):  
Yew Kong Lee ◽  
Ping Yein Lee ◽  
Ai Theng Cheong ◽  
Chirk Jenn Ng ◽  
Khatijah Lim Abdullah ◽  
...  

2003 ◽  
Vol 21 (2) ◽  
pp. 93-100 ◽  
Author(s):  
Donna L Berry ◽  
William J Ellis ◽  
Nancy Fugate Woods ◽  
Christina Schwien ◽  
Kristin H Mullen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document